Insider Transactions in Q1 2023 at Elanco Animal Health Inc (ELAN)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2023
|
Todd S. Young |
BUY
Bona fide gift
|
Indirect |
4,000
+50.0%
|
-
|
Mar 15
2023
|
Todd S. Young |
SELL
Bona fide gift
|
Indirect |
4,000
-1.71%
|
-
|
Mar 14
2023
|
Todd S. Young |
BUY
Bona fide gift
|
Indirect |
118,309
+50.0%
|
-
|
Mar 14
2023
|
Todd S. Young |
SELL
Bona fide gift
|
Direct |
118,309
-57.37%
|
-
|
Mar 14
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+2.94%
|
$45,000
$9.55 P/Share
|
Mar 13
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.03%
|
$45,000
$9.46 P/Share
|
Mar 10
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Open market or private purchase
|
Indirect |
15,000
+25.0%
|
$135,000
$9.6 P/Share
|
Mar 05
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,696
-0.93%
|
$117,656
$11.1 P/Share
|
Mar 03
2023
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.06%
|
$110,000
$11.13 P/Share
|
Mar 02
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
147,031
-5.8%
|
$1,617,341
$11.01 P/Share
|
Mar 02
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
316,386
+19.68%
|
-
|
Mar 02
2023
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
13,428
-4.81%
|
$147,708
$11.01 P/Share
|
Mar 02
2023
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
28,571
+16.74%
|
-
|
Mar 02
2023
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
15,561
-5.35%
|
$171,171
$11.01 P/Share
|
Mar 02
2023
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
33,502
+18.47%
|
-
|
Mar 02
2023
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
6,801
-14.24%
|
$74,811
$11.01 P/Share
|
Mar 02
2023
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
15,107
+24.04%
|
-
|
Mar 02
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,797
-2.7%
|
$19,767
$11.01 P/Share
|
Mar 02
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,659
+19.74%
|
-
|
Mar 02
2023
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
31,249
-6.82%
|
$343,739
$11.01 P/Share
|
Mar 02
2023
|
Todd S. Young |
BUY
Grant, award, or other acquisition
|
Direct |
66,655
+22.08%
|
-
|
Mar 02
2023
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
18,887
-6.21%
|
$207,757
$11.01 P/Share
|
Mar 02
2023
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
40,423
+20.64%
|
-
|
Mar 01
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
248,668
+20.06%
|
-
|
Mar 01
2023
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
12,662
-1.68%
|
$139,282
$11.26 P/Share
|
Mar 01
2023
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
37,745
+24.36%
|
-
|
Mar 01
2023
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
3,490
-4.21%
|
$38,390
$11.26 P/Share
|
Mar 01
2023
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
22,270
+16.21%
|
-
|
Mar 01
2023
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-2.6%
|
$27,302
$11.26 P/Share
|
Mar 01
2023
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
26,577
+18.64%
|
-
|
Mar 01
2023
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
2,923
-3.16%
|
$32,153
$11.26 P/Share
|
Mar 01
2023
|
Todd S. Young |
BUY
Grant, award, or other acquisition
|
Direct |
58,060
+25.19%
|
-
|
Mar 01
2023
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
5,600
-4.67%
|
$61,600
$11.26 P/Share
|
Mar 01
2023
|
Ellen De Brabander |
BUY
Grant, award, or other acquisition
|
Direct |
45,338
+33.06%
|
-
|
Mar 01
2023
|
Ellen De Brabander |
SELL
Payment of exercise price or tax liability
|
Direct |
2,368
-4.85%
|
$26,048
$11.26 P/Share
|
Mar 01
2023
|
Marcela A. Kirberger |
BUY
Grant, award, or other acquisition
|
Direct |
33,304
+40.52%
|
-
|
Mar 01
2023
|
Marcela A. Kirberger |
SELL
Payment of exercise price or tax liability
|
Direct |
1,707
-9.87%
|
$18,777
$11.26 P/Share
|
Mar 01
2023
|
Rajeev A. Modi |
BUY
Grant, award, or other acquisition
|
Direct |
23,313
+26.0%
|
-
|
Mar 01
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,659
+24.35%
|
-
|
Mar 01
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-3.56%
|
$7,403
$11.26 P/Share
|
Mar 01
2023
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
14,432
+30.66%
|
-
|
Mar 01
2023
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
1,400
-7.14%
|
$15,400
$11.26 P/Share
|
Feb 01
2023
|
Todd S. Young |
BUY
Conversion of derivative security
|
Indirect |
1,562
+19.23%
|
-
|
Jan 03
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-2.08%
|
$4,824
$12.35 P/Share
|